Clinical trials recruiting for Metastatic Colorectal Carcinoma
13
Recruiting trials
23
US states with sites
5
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Fluorouracil | 3 |
| Cetuximab | 2 |
| Irinotecan | 2 |
| Leucovorin | 2 |
| Oxaliplatin | 2 |
| BET Bromodomain Inhibitor ZEN-3694 | 1 |
| Bevacizumab | 1 |
| Capecitabine | 1 |
| Cisplatin | 1 |
| Devimistat | 1 |
| Doxorubicin | 1 |
| Encorafenib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 6 |
| California | 3 |
| Illinois | 3 |
| New York | 3 |
| Texas | 3 |
| Arizona | 2 |
| Minnesota | 2 |
| Missouri | 2 |
| Ohio | 2 |
| Pennsylvania | 2 |
| Tennessee | 2 |
| Alabama | 1 |
Top cities
Jacksonville, Florida 4Chicago, Illinois 2City of Saint Peters, Missouri 2Creve Coeur, Missouri 2Houston, Texas 2Nashville, Tennessee 2New York, New York 2Phoenix, Arizona 2Pittsburgh, Pennsylvania 2Rochester, Minnesota 2
Self-screener
Recruiting trials
- An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
- BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Intravital Microscopy in Human Solid Tumors
- Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Related conditions
Trials recruiting for Metastatic Colorectal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Stage IV Colorectal Cancer AJCC v8 21Stage IVC Colorectal Cancer AJCC v8 7Stage IVB Colorectal Cancer AJCC v8 7Stage IVA Colorectal Cancer AJCC v8 7Metastatic Malignant Solid Neoplasm 21Stage IV Renal Cell Cancer AJCC v8 9Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 3Pancreatic cancer 870Metastatic Urothelial Carcinoma 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Colorectal Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.